π©Ή CPT 11043 β Debridement, Muscle and/or Fascia; First 20 Sq Cm or Less
Quick Reference
wRVU: 2.10 | Global Period: 000 (Same Day) | Assistant Payable: β No | Bilateral Indicator: 3
π Clinical Description
CPT 11043 describes surgical debridement that extends through the skin and subcutaneous tissue into the fascia and/or muscle layer β including removal of overlying epidermis, dermis, and subcutaneous tissue when performed β for a wound measuring 20 sq cm or less. The physician removes devitalized, necrotic, or infected muscle and/or fascial tissue using sharp instruments, with the goal of eliminating the source of infection and creating a viable wound bed. The critical differentiator between this code and 11042 is depth β 11043 requires documented penetration into fascia or muscle; when debridement is limited to subcutaneous tissue, 11042 is the correct code. When debridement reaches bone, 11044 is reported instead.
Deep tissue necrosis β involving the fascial planes or muscle bellies β most commonly occurs as a complication of longstanding diabetic foot ulcers, Stage 4 pressure injuries, necrotizing soft tissue infections (including necrotizing fasciitis), traumatic wounds, and post-surgical dehiscence with deep tissue involvement. Left untreated, deep tissue necrosis rapidly progresses to osteomyelitis, sepsis, and limb loss; 11043 represents an intermediate and often urgent level of debridement between subcutaneous (11042) and bone-level (11044) debridement.
This procedure may be performed in the following clinical contexts:
- Stage 4 Pressure Injury β Full-thickness tissue loss with exposed or palpable fascia, muscle, tendon, or bone; when debridement is limited to muscle/fascia with intact bone, 11043 is correct; escalate to 11044 if bone is reached
- Diabetic Foot Ulcer with Deep Tissue Involvement β Debridement of necrotic muscle or fascia in a DFU where subcutaneous debridement (11042) has been insufficient or the wound has progressed; documentation must confirm fascial or muscle layer involvement
- Necrotizing Fasciitis β Limited Debridement β Surgical removal of necrotic fascia in a patient with confirmed or suspected necrotizing fasciitis; note that extensive necrotizing soft tissue infection of genitalia/perineum/abdominal wall uses 11004-11006 instead
- Post-Traumatic Deep Wound Infection β Debridement of devitalized muscle and fascia in a traumatic wound (laceration, puncture, crush injury) with deep tissue involvement and documented infection or necrosis
- Planned Serial Debridement β Deep Tier β When a patient with a previously debrided wound (11042) returns and the wound has progressed or a new necrotic layer is identified at fascial depth, 11043 is appropriate for that session; each visit requires independent documentation of depth
π¬ Anatomical & Procedural Considerations
| Technique Variant | Mechanism / Steps | Key Notes |
|---|---|---|
| Sharp / Surgical Debridement | Scalpel, scissors, and/or curette used to excise devitalized tissue layer by layer through fascia and/or into muscle | Operative note must document instruments used, tissue type removed at each layer, and the depth at which viable tissue was encountered β fascia vs. muscle must be specified |
| Hydrosurgical / Versajet | High-pressure waterjet system excises necrotic tissue with precision through deep layers | Acceptable for 11043 when documentation confirms fascial/muscle depth; no separate equipment code β bundled |
| Electrosurgical Debridement | Monopolar or bipolar electrocautery used for concurrent hemostasis and tissue ablation | More commonly a hemostatic adjunct than the primary debridement modality; primary sharp debridement should be leading documentation |
| Combination Approach | Initial sharp debridement of subcutaneous layer followed by fascial/muscle debridement | Only 11043 is reported β it includes overlying tissue removal; do not report 11042 in addition to 11043 for the same wound site |
Clinical Pearl
The operative/procedure note must explicitly document that debridement reached the fascia and/or muscle layer β language such as βfascial planes debrided,β βnecrotic muscle excised,β βdebridement to viable muscle,β or βfascia encountered and debridedβ is required. A note that states only βdeep debridementβ or βsubcutaneous and deeper tissue debridementβ without naming the specific layer is insufficient to defend 11043 on audit and will be downcoded to 11042. This is the single most common audit finding for this code family β document the deepest layer reached, by name, every time.
β Procedure Includesβ¦
- Pre-procedure wound assessment confirming depth and tissue viability at fascial/muscle level
- Local or regional anesthesia when administered (bundled β not separately billable for office-based procedure)
- Active surgical removal of devitalized, necrotic, or infected fascia and/or muscle tissue
- Removal of overlying epidermis, dermis, and subcutaneous tissue as part of the access and debridement pathway
- Wound bed assessment during procedure, including identification of viable vs. non-viable tissue at each layer
- Wound irrigation, hemostasis, and application of primary dressing at conclusion of procedure
- Documentation of wound dimensions (sq cm), tissue layers removed by name, depth reached, and instruments used
β Excludes / Do Not Report Together
| Code | Description | Relationship to 11043 |
|---|---|---|
| 11042 | Debridement, subcutaneous tissue; first 20 sq cm | Do not report 11042 with 11043 for the same wound same session β 11043 includes overlying subcutaneous and skin layer removal by definition; reporting both is an NCCI bundling violation |
| 11046 | Debridement, muscle and/or fascia; each additional 20 sq cm | This is the correct add-on code to 11043 for wound surface areas exceeding 20 sq cm; report in addition to 11043 for each additional 20 sq cm increment of the same wound |
| 11044 | Debridement, bone; first 20 sq cm | Report 11044 instead of 11043 when debridement reaches bone (e.g., exposed cortex, osteomyelitis); 11044 subsumes all superficial layers at the same operative site β do not report both |
| 97597 | Debridement, open wound; selective, first 20 sq cm | 97597 is for debridement confined to epidermis/dermis only; mutually exclusive with 11043 by depth; never report together for the same wound |
| 11004 | Debridement of skin, subcutaneous tissue, muscle, fascia β external genitalia and perineum | 11004 is the appropriate code for necrotizing soft tissue infections of the genitalia/perineum involving fascial/muscle debridement β use 11004 for that anatomic site, not 11043 |
| E/M codes (992xx / 920xx) | Office visit, any level | Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-procedure wound assessment |
Bundling Alert β Global Period is 000, Not 010 or 090
CPT 11043 carries a 000 global period (same-day only). The global package includes only same-day pre- and post-procedure services β any follow-up wound visit the next day or later is separately billable without a modifier. The most common error is applying a 10-day or 90-day mental block to debridement codes based on habit from minor excision or major surgical code experience. Do not confuse the 000 global with a βno globalβ situation β same-day pre-procedure evaluation IS bundled. For an unrelated condition seen the same day, modifier -24 applies to the E/M with explicit documentation that the visit is unrelated to the debridement.
π³ Code Tree β Surgery: Skin, Subcutaneous and Accessory Structures
CPT 11000-11047 Debridement
β
βββ 11000-11001 Debridement β Infected/Eczematous Skin
β βββ 11000 Debridement of extensive eczematous or infected skin; up to 10% of body surface area
β βββ 11001 Each additional 10% body surface area (add-on)
β
βββ 11004-11008 Debridement β Necrotizing Soft Tissue (Genitalia/Perineum/Abdominal Wall)
β βββ 11004 Debridement of skin, subcutaneous tissue, muscle, fascia β external genitalia and perineum
β βββ 11005 Debridement β abdominal wall (fascia)
β βββ 11006 Debridement β external genitalia, perineum, abdominal wall
β βββ 11008 Removal of prosthetic material, infected (add-on)
β
βββ 11010-11012 Debridement β Fracture and/or Dislocation
β βββ 11010 Debridement including removal of foreign body; skin and subcutaneous tissue
β βββ 11011 Skin, subcutaneous tissue, and muscle
β βββ 11012 Skin, subcutaneous tissue, muscle, and bone
β
βββ 11042-11047 Debridement β Subcutaneous / Deeper Tissue (Non-Infected/Chronic Wound)
β βββ 11042 Debridement, subcutaneous tissue; first 20 sq cm or less (Global: 000)
β βββ 11045 Debridement, subcutaneous tissue; each additional 20 sq cm (add-on to 11042) (Global: ZZZ)
β βββ βΆβΆ 11043 ββ Debridement, muscle and/or fascia; first 20 sq cm β YOU ARE HERE (Global: 000)
β βββ 11046 Debridement, muscle and/or fascia; each additional 20 sq cm (add-on to 11043) (Global: ZZZ)
β βββ 11044 Debridement, bone; first 20 sq cm (Global: 000)
β βββ 11047 Debridement, bone; each additional 20 sq cm (add-on to 11044) (Global: ZZZ)
π° RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 2.10 (verify against current CMS MPFS for applicable year) |
| Global Period | 000 (Same Day) |
| Bilateral Indicator | 3 β Bilateral surgery concept does not apply; no bilateral reduction applied |
| Assistant Surgeon | β Not payable |
| Co-Surgeon | β Not applicable |
| Team Surgery | β Not applicable |
| PC/TC Split | β No β Procedure code only (Indicator 0) |
| Modifier -51 Exempt | No β subject to multiple procedure reduction rules |
| Anesthesia | Local or regional anesthesia for office-based procedures; general anesthesia separately billable under applicable anesthesia codes when debridement is performed in the OR setting |
Bilateral Billing Rules
CPT 11043 has a bilateral indicator of 3, meaning the bilateral surgery concept does not apply β no standard bilateral reduction is applied even when debridement is performed on two anatomically distinct wound sites in the same session. Each separate wound is billed on its own claim line using modifier -59 or -XS (separate structure) to document the distinct service. Document each wound with its own dimensions, anatomic location, depth reached, and tissue type removed. There is no Medicare 150% bilateral reduction rule for this code.
π·οΈ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code β not 11043 β when a separately identifiable office visit is performed on the same date; documentation must support a distinct, medically necessary evaluation beyond the pre-procedure wound assessment |
| -24 | Unrelated E/M During Postoperative Period | Applied to the E/M code when a patient is seen same day for a condition entirely unrelated to the debridement; document unrelated nature explicitly in the note |
| -51 | Multiple Procedures | When 11043 is performed alongside other surgical procedures in the same session; apply to the lower-valued code per standard multiple procedure reduction rules |
| -52 | Reduced Services | Procedure partially completed (e.g., patient could not tolerate full debridement of identified necrotic area) β document clinical reason thoroughly |
| -53 | Discontinued Procedure | Procedure stopped due to patient safety concern after initiation; document reason; use for procedures stopped after initiation but before completion |
| -58 | Staged or Related Procedure | When serial debridement is planned and a subsequent session is performed; reference the original procedure date and confirm planned staging in the initial note |
| -59 | Distinct Procedural Service | When 11043 is performed on an anatomically distinct wound from another debridement or procedure billed on the same date; documents separate site |
| -76 | Repeat Procedure by Same Physician | When 11043 is repeated on the same day by the same provider (uncommon; document medical necessity clearly) |
| -77 | Repeat Procedure by Different Physician | Same-day repeat debridement of the same wound by a different provider |
| -XS | Separate Structure | Preferred X-modifier over -59 when billing 11043 for two anatomically distinct wound sites on the same date of service |
| -XU | Unusual Non-Overlapping Service | When a payer inappropriately bundles 11043 with a distinct non-overlapping wound service |
π©Ί Common ICD-10-CM Pairings
Non-Pressure Chronic Ulcers β Muscle/Fascia Depth
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| L97.313 | Non-pressure chronic ulcer of right ankle with necrosis of muscle | β No | βNecrosis of muscleβ = muscle layer involvement; directly supports 11043 over 11042; laterality required |
| L97.323 | Non-pressure chronic ulcer of left ankle with necrosis of muscle | β No | Left side equivalent; document laterality at every visit |
| L97.413 | Non-pressure chronic ulcer of right heel and midfoot with necrosis of muscle | β No | Common DFU location; muscle necrosis character confirms 11043 depth |
| L97.423 | Non-pressure chronic ulcer of left heel and midfoot with necrosis of muscle | β No | Left heel/midfoot with muscle necrosis |
| L97.513 | Non-pressure chronic ulcer of other part of right foot with necrosis of muscle | β No | Non-heel/midfoot right foot ulcer with muscle involvement |
| L97.523 | Non-pressure chronic ulcer of other part of left foot with necrosis of muscle | β No | Non-heel/midfoot left foot ulcer with muscle involvement |
Pressure Injuries β Stage 4
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| L89.214 | Pressure ulcer of right hip, stage 4 | β No | Stage 4 = full-thickness loss with exposed fascia, muscle, tendon, or bone; 11043 correct when fascia/muscle is the deepest layer debrided; escalate to 11044 if bone reached |
| L89.224 | Pressure ulcer of left hip, stage 4 | β No | Left hip, Stage 4; assign separately if both hips involved |
| L89.314 | Pressure ulcer of right buttock, stage 4 | β No | High-frequency location for Stage 4 pressure injuries in immobile patients |
| L89.324 | Pressure ulcer of left buttock, stage 4 | β No | Left buttock; document each site separately |
| L89.154 | Pressure ulcer of sacral region, stage 4 | β No | Sacral Stage 4 β particularly common in ICU/bedridden patients |
Diabetic Ulcers with Deep Tissue Involvement
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| E11.621 | Type 2 diabetes mellitus with foot ulcer | β HCC 18 | Assign with an additional L97.- code identifying the site and depth; E11.621 alone does not capture wound depth |
| E10.621 | Type 1 diabetes mellitus with foot ulcer | β HCC 17 | Confirm type and insulin status in documentation; add L97.- for site specificity |
| E11.622 | Type 2 DM with other skin ulcer | β HCC 18 | Non-foot diabetic ulcer involving muscle/fascia β use with L97.- or L98.- to identify the site |
| E13.621 | Other specified diabetes mellitus with foot ulcer | β HCC 18 | Secondary DM (e.g., post-pancreatectomy, steroid-induced); add L97.- for site specificity |
Underlying Etiology / Complication Codes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| M72.6 | Necrotizing fasciitis | β HCC 39 | Assign as principal or secondary diagnosis when necrotizing fasciitis is confirmed or suspected; directly drives medical necessity for deep fascial debridement under 11043 |
| M86.171 | Other acute osteomyelitis, right ankle | β HCC 39 | When osteomyelitis is documented, escalate debridement code to 11044 (bone); do not assign 11043 if bone is reached |
| I87.2 | Venous insufficiency (chronic) (peripheral) | β No | Underlying etiology for venous stasis ulcers extending to fascial depth; assign as additional diagnosis |
| L03.115 | Cellulitis of right lower limb | β No | Active cellulitis as complicating or surrounding infection; supports medical necessity for deep debridement |
| T79.3XXA | Post-traumatic wound infection, initial encounter | β No | Infected traumatic wound at initial encounter; subsequent encounters use suffix D |
Coding Specificity Reminder
The most critical specificity axis for 11043βs ICD-10-CM pairings is the depth/severity character in the L97.- and L89.- code families β specifically the characters identifying βnecrosis of muscleβ (character 3) versus βfat layer exposedβ (character 1) versus βbone necrosisβ (character 4). The operative note is your documentation source for this character β when the provider documents βnecrotic muscle debrided,β the L97.-3 severity character is supported. When the note describes only βslough and subcutaneous tissue,β the L97.-3 character is not supported and you must code to the appropriate lesser depth. ICD-10-CM specificity requirements are not optional β the procedure note and the diagnosis code must tell the same clinical story.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 11043 is performed primarily in the outpatient, office, and ASC setting for routine wound care. However, when deep muscle/fascial debridement is performed in the inpatient setting β most commonly for necrotizing fasciitis, infected diabetic wounds with systemic sepsis, or Stage 4 pressure injuries in medically complex patients β ICD-10-PCS codes are assigned rather than CPT. The ICD-10-PCS Extraction root operation under Body System K (Muscles) is used; these codes, combined with a principal diagnosis of necrotizing fasciitis (M72.6) or sepsis with a skin/soft tissue source, may contribute to MDC 08 (Musculoskeletal) or MDC 09 (Skin and Subcutaneous Tissue) grouping depending on principal diagnosis. CC/MCC documentation (e.g., sepsis, osteomyelitis, DM with complications) significantly impacts DRG tier and reimbursement β CDI query opportunity when these comorbidities are present but not explicitly linked.
π§ ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
Inpatient PCS coding for muscle/fascia debridement uses the Extraction root operation (character D) under Body System K (Muscles) for muscle involvement, or Body System J (Subcutaneous Tissue and Fascia) for isolated fascial debridement. The Open approach (character 0) is used for sharp surgical debridement. PCS codes do not capture wound surface area (sq cm) β a single PCS code covers the debridement of the designated body part; when multiple muscle groups or body parts are debrided, assign a separate PCS code for each body part per PCS guideline B3.2b.
| PCS Code | Full Description | Applicable Approach |
|---|---|---|
0KDD0ZZ | Extraction of Lower Leg Muscle, Right, Open Approach | Sharp debridement β right lower leg muscle |
0KDF0ZZ | Extraction of Lower Leg Muscle, Left, Open Approach | Sharp debridement β left lower leg muscle |
0KDW0ZZ | Extraction of Foot Muscle, Right, Open Approach | Sharp debridement β right foot muscle (DFU) |
0KDX0ZZ | Extraction of Foot Muscle, Left, Open Approach | Sharp debridement β left foot muscle (DFU) |
0KDB0ZZ | Extraction of Upper Leg Muscle, Right, Open Approach | Sharp debridement β right thigh muscle |
0KDC0ZZ | Extraction of Upper Leg Muscle, Left, Open Approach | Sharp debridement β left thigh muscle |
0JDB0ZZ | Extraction of Subcutaneous Tissue and Fascia, Right Lower Leg, Open Approach | Isolated fascial debridement β right lower leg |
0JDC0ZZ | Extraction of Subcutaneous Tissue and Fascia, Left Lower Leg, Open Approach | Isolated fascial debridement β left lower leg |
PCS Character Analysis β 0KDD0ZZ
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | K | Muscles |
| 3 | Root Operation | D | Extraction (pulling or stripping out or off all or a portion of a body part by the use of force) |
| 4 | Body Part | D | Lower Leg Muscle, Right |
| 5 | Approach | 0 | Open |
| 6 | Device | Z | No Device |
| 7 | Qualifier | Z | No Qualifier |
PCS Root Operation: Extraction (D) vs. Excision (B) β Muscle Debridement
- Use Extraction (D) when debridement involves scraping, stripping, or pulling away necrotic muscle tissue β the dominant root operation for debridement in PCS regardless of depth
- Use Excision (B) only when a discrete, defined piece of muscle is cut out by sharp instrument and the intent is removal of a specific tissue mass (e.g., tumor, abscess), not wound bed preparation
- When both fascial and muscle layers are debrided at the same site, assign a PCS code for the deepest layer (Body System K β Muscles) as the primary code; the overlying fascial work is considered included per PCS guideline B3.1b β do not assign both a Body System J and Body System K code for the same operative site in the same session
π Coding Examples
Example 1 β Office: Stage 4 Pressure Ulcer, Muscle/Fascia Debridement
Clinical Scenario: A 76-year-old female nursing home resident presents to a wound care clinic for management of a Stage 4 pressure ulcer of the right buttock. Examination reveals a 14 sq cm wound with visible necrotic muscle and fascia. The provider documents: βSharp debridement performed with scalpel and curette; necrotic fascia and underlying muscle tissue removed to viable bleeding muscle; wound measures 14 sq cm; bone not encountered; dressing applied.β No separately documented E/M beyond wound care assessment.
| Field | Code | Rationale |
|---|---|---|
| CPT | 11043 | Muscle and fascia debridement β€20 sq cm; note explicitly documents necrotic fascia and muscle removed; bone not encountered β 11044 not applicable |
| PDx | L89.314 | Pressure ulcer of right buttock, Stage 4 β Stage 4 by definition involves tissue loss to fascia/muscle level; directly supports 11043 |
Note
No modifier -25 is applicable here because no separately documented E/M beyond wound care assessment is noted. The pre-procedure evaluation is bundled into the 11043 same-day global (000) package. If the provider had addressed an unrelated new complaint with a distinct history, exam, and MDM, the E/M with -25 would be separately billable.
Example 2 β Outpatient Hospital: Diabetic Foot Ulcer, Two Wounds, Separate Sites
Clinical Scenario: A 58-year-old male with Type 2 diabetes mellitus presents to the outpatient wound care center. He has two wounds: a 16 sq cm left heel ulcer with documented necrotic muscle, and a separate 12 sq cm right ankle ulcer with fat layer exposed (subcutaneous depth only). The provider documents separate wound assessments, instruments, depth findings, and dressings for each site. A separate E/M is also documented for a new complaint of worsening neuropathic pain with distinct history and MDM noted.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 99213-25 | Separately identifiable E/M for new neuropathic pain complaint β modifier -25 on the E/M code; documentation supports distinct visit beyond wound care |
| CPT 2 | 11043[-XS] | Left heel debridement to muscle layer, β€20 sq cm; -XS documents separate structure from right ankle |
| CPT 3 | 11042-59 | Right ankle debridement to subcutaneous layer only, β€20 sq cm; note explicitly limits depth to subcutaneous fat β 11043 not appropriate for this wound |
| PDx | E11.621 | Type 2 DM with foot ulcer β principal diagnosis driving both wound care encounters |
| SDx | L97.423 | Left heel/midfoot non-pressure ulcer with necrosis of muscle β supports 11043 for left heel |
| SDx | L97.311 | Right ankle non-pressure ulcer with fat layer exposed β supports 11042 for right ankle |
Warning
Modifier -25 belongs on the E/M code, never on 11043 or 11042. Additionally, note that 11043 and 11042 are billed for different wound sites here β do not report 11043 and 11042 together for the same wound. The fact that two different depths are documented for two different anatomic wounds is what makes this billing valid; clear, wound-specific documentation of depth at each site is the audit defense.
Example 3 β ASC: Planned Serial Debridement, Progression from 11042 to 11043
Clinical Scenario: A 67-year-old male with a non-healing right lower leg ulcer and peripheral vascular disease underwent initial debridement coded as 11042 on April 10 (subcutaneous depth, 18 sq cm). He returns to the ASC on April 21 for a second debridement session. The April 21 procedure note documents: βOn inspection, wound has progressed with necrotic fascia now visible at wound base; sharp debridement performed with scalpel; necrotic fascia excised to viable tissue; muscle intact and not debrided; wound measures 17 sq cm; planned staged debridement, second session.β Modifier -58 is applied.
| Field | Code | Rationale |
|---|---|---|
| CPT | 11043-58 | Debridement now reaching fascia (deeper than April 10βs subcutaneous level); -58 documents staged/related procedure in planned series; note explicitly names fascia as the deepest layer |
| PDx | L97.313 | Non-pressure chronic ulcer of right ankle with necrosis of muscle β query provider: note documents fascial debridement; if muscle involvement is also confirmed, L97.313 is appropriate; if fascia only, query for the most specific code available |
| SDx | I70.213 | Atherosclerosis of native arteries of extremities with ulceration, right leg β peripheral vascular disease as underlying etiology; supports medical necessity narrative |
Note
Global period reminder: The April 10 procedure (11042) carries a 000 global period β same day only. The April 21 visit is outside the same-day global and is separately billable without a mandatory modifier on that basis alone. Modifier -58 is applied here for payer transparency to document the planned staged relationship between the two procedures, which helps prevent inappropriate claim denial. Note the escalation from 11042 to 11043 β this is clinically appropriate when wound progression is documented; do not report the same depth code if the operative note documents a deeper layer on the follow-up visit.
β οΈ Common Coding Pitfalls
-
Failure to Document the Specific Tissue Layer Reached: The procedure note must name the exact layer debrided β βfascia,β βfascial planes,β βmuscle,β or βnecrotic muscle excisedβ are required phrases. Notes stating βdeep debridement performedβ or βall necrotic tissue removedβ without naming the layer are insufficient to support 11043 and will be downcoded to 11042 on audit, resulting in reimbursement loss and potential recoupment liability.
-
Reporting 11042 and 11043 Together for the Same Wound: CPT 11043 includes removal of overlying epidermis, dermis, and subcutaneous tissue by definition. Billing 11042 alongside 11043 for the same wound site is an NCCI bundling violation. When debridement reaches fascia or muscle, only 11043 is reported β the subcutaneous component is subsumed. The only time both codes are valid on the same date is when they describe debridement of two distinct, anatomically separate wounds.
-
Missing Add-On Code 11046 for Large Wounds: When a single wound requiring muscle/fascia debridement exceeds 20 sq cm, CPT 11043 covers the first 20 sq cm and CPT 11046 is required for each additional 20 sq cm. Failing to append 11046 for a 38 sq cm wound means leaving legitimate reimbursement unbilled. Document total wound surface area in sq cm in every procedure note β the add-on code cannot be supported without it.
-
Billing -25 on the Procedure Code Instead of the E/M: Modifier -25 must be appended to the E/M service code, not to CPT 11043. This is an extremely common compliance finding in wound care billing audits. The E/M documentation must stand independently as a significant, separately identifiable service beyond the wound care pre-procedure evaluation β wound measurement alone does not meet this bar.
-
Escalating to 11043 When 11044 Is Correct: When the procedure note documents that debridement reached bone β even incidentally, even if bone debridement was not the primary intent β CPT 11044 is the appropriate code, not 11043. Read the operative note carefully for language such as βbone visible,β βcortex encountered,β βbone debrided,β or βperiosteum removed.β Assigning 11043 when bone was reached constitutes undercoding when identified internally, or a potential coding error if identified on audit.
-
Defaulting to Unspecified ICD-10-CM Without Querying: The L97.- and L89.- code families include a severity/depth character that maps directly to the operative note findings. Assigning an unspecified code (e.g., L97.319 β right ankle ulcer, unspecified severity) when the procedure note documents necrotic muscle is a missed coding opportunity and a specificity failure. Query the provider or use the documented depth from the procedure note to assign the most specific character available before defaulting to unspecified.
π Sources
1. AMA CPT 2025 Professional Edition β Code 11043, Debridement Procedures on the Skin Β· 2. CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) β RVU and Global Period Assignments Β· 3. CMS RVU25A Relative Value Files β Work RVU: 2.10, Global Period: 000, Bilateral Indicator: 3 Β· 4. NCCI Policy Manual Chapter 1 & Chapter 4 (Integumentary System), CMS 2024-2025 β Debridement Bundling and Mutually Exclusive Code Rules Β· 5. ICD-10-CM Official Guidelines for Coding and Reporting FY2025 β Section I.C.12 (Diseases of the Skin and Subcutaneous Tissue), Section I.C.4 (Endocrine Diseases/Diabetic Ulcers) Β· 6. ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 β Root Operation Extraction, Body Systems J and K; Guideline B3.1b, B3.2b Β· 7. CMS Article A58567 β Billing and Coding: Wound and Ulcer Care (MAC LCD Companion Article) Β· 8. AAPC Wound Care and General Surgery Coding Guidelines β CPT 11043 Depth Documentation Requirements Β· 9. Palmetto GBA Jurisdiction M β Surgical Debridement LCD/Policy Β· 10. CMS Medicare Coverage Database Article A55909 β Wound Care (as updated)
Crystal's Coder Hub